000 | 01168 a2200301 4500 | ||
---|---|---|---|
005 | 20250513094200.0 | ||
264 | 0 | _c19961017 | |
008 | 199610s 0 0 eng d | ||
022 | _a0960-5371 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCasey, D E | |
245 | 0 | 0 |
_aExtrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models. _h[electronic resource] |
260 |
_bThe British journal of psychiatry. Supplement _cMay 1996 |
||
300 |
_a32-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
650 | 0 | 4 |
_aBasal Ganglia Diseases _xchemically induced |
650 | 0 | 4 | _aCebus |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
650 | 0 | 4 | _aSchizophrenic Psychology |
773 | 0 |
_tThe British journal of psychiatry. Supplement _gno. 29 _gp. 32-9 |
|
999 |
_c8730892 _d8730892 |